ANN ARBOR, Mich., Oct. 12, 2021 /PRNewswire/ -- Patients diagnosed with a rare cancer called Epithelioid Sarcoma face many challenges that will impact their outcome, beginning with the lengthy ...
Leila Janah, a fierce entrepreneur who worked to help those living below the poverty line, died in January from complications of epithelioid sarcoma -- a form of cancer. Leila Janah, a fierce ...
Now an MSK research team led by physician-scientist Alex Kentsis, MD, PhD, together with Dr. Gounder and colleagues, has identified mechanisms that activate resistance to tazemetostat in epithelioid ...
Epithelioid sarcoma is a rare and aggressive soft-tissue tumour that poses significant diagnostic and therapeutic challenges. Characterised principally by the loss of SMARCB1/INI1 expression, the ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved sirolimus protein-bound particles for injectable suspension (albumin-bound) for treatment of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (Nasdaq:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing novel epigenetic therapies, today announced that the U.S. Food ...
PARIS, FRANCE, 09 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik ® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s ...
JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results